Emerillon, Fonds de solidarité FTQ invest in Searchlight Pharma
Montréal specialty pharmaceutical company Searchlight Pharma Inc has secured an undisclosed investment from Emerillon Capital, managed by CIC Capital Canada, and Fonds de solidarité FTQ. The investment will support the company's organic and acquisition-based growth and therapeutic area expansion. Founded in 2015, Searchlight has a core focus on women's health, urology, and pediatrics. It has so far closed nine deals that have contributed 15 marketed products, with additional pipeline candidates expected to launch over the next 12 to 18 months. Searchlight is led by President and CEO Mark Nawacki.
25 October 2017•4 mins read
